Jeanne M. Gills Discusses the Value of Diversity in the Legal Profession
14 July 2023
ManagingIP
Foley & Lardner LLP partner Jeanne M. Gills is quoted in the ManagingIP article, “Firms to press on with diversity plans despite SCOTUS setback,” discussing the importance of diversity in the legal profession following the U.S. Supreme Court’s recent decision on affirmative action.
Gills said she would encourage firms and corporations to continue the work they have been doing to advance diverse talent. “When we bring a diversity of thought, leadership, and experience, it allows us to think differently about how to create opportunities and solve problems,” Gills commented. “As a leader within my firm, I’m not going to stop what I’m doing because I’ve seen over the course of my 30 years, the success that comes from having diverse teams.”
People
Related News
06 September 2024
In the News
Old Employment Law Principles Can Answer New AI Concerns
The integration of artificial intelligence into the workplace has sparked a flurry of legal and regulatory discussions in recent months.
06 September 2024
In the News
Nathaniel Lacktman, Foley's 50-State Survey of Telehealth Insurance Laws Highlighted for Guidance on Legal Landscape
Foley & Lardner LLP partner Nathaniel Lacktman, chair of the firm’s national Telemedicine & Digital Health Industry Team and member of the American Telemedicine Association Board of Directors, discussed telehealth reimbursement parity, exclusivity contracts, and remote patient monitoring in the Managed Healthcare Executive article, “Telehealth is a Go, and States Are Having Their Say So.”
05 September 2024
In the News
Nathaniel Lacktman on Potential DEA Telemedicine Prescribing Crackdown – 'It's putting doctors in a really difficult situation'
Foley & Lardner LLP partner Nathaniel Lacktman, chair of firm’s national Telemedicine & Digital Health Industry Team and member of the American Telemedicine Association Board of Directors, discussed the potential consequences of the U.S. Drug Enforcement Agency enacting regressive regulations on telemedicine prescribing in Endpoints News, a Financial Times publication.